MSAC - Meeting 26-27 July 2018

Medical Services Advisory Committee - Applications Considered

• 1196.1 – Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression
• 1440.1 - PD-L1 testing for access to pembrolizumab in treatment naïve patients with locally advanced or metastatic non-small cell lung cancer
• 1454 - Diagnostic testing for ROS proto-oncogene 1 (ROS1) rearrangements in non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment
• 1476 - Clinical Utility Card - Genetic Testing for childhood syndromes
• 1485 - Sentinel lymph node biopsy for intermediate thickness melanoma
• 1491 - Vagus Nerve Stimulation for chronic major depressive episodes
• 1492 - Non-Invasive Prenatal Testing (NIPT) for common Trisomies (21, 18 and 13)
• 1493 - Transarterial radioembolisation with yttrium-90 (TARE-Y) for the treatment of unresectable hepatocellular carcinoma (HCC)
• 1504 - Clinical Utility Card - Heritable mutations which increase risk in colorectal and endometrial cancer
• 1511 - Extended half-life clotting factor concentrates for treatment of haemophilia A and B